1. Home
  2. OPAL vs VTGN Comparison

OPAL vs VTGN Comparison

Compare OPAL & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OPAL Fuels Inc.

OPAL

OPAL Fuels Inc.

N/A

Current Price

$2.22

Market Cap

71.6M

Sector

Utilities

ML Signal

N/A

Logo VistaGen Therapeutics Inc.

VTGN

VistaGen Therapeutics Inc.

HOLD

Current Price

$0.25

Market Cap

25.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OPAL
VTGN
Founded
1998
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Natural Gas Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
71.6M
25.3M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
OPAL
VTGN
Price
$2.22
$0.25
Analyst Decision
Sell
Hold
Analyst Count
3
3
Target Price
$2.72
$0.90
AVG Volume (30 Days)
182.1K
2.8M
Earning Date
05-11-2026
06-16-2026
Dividend Yield
N/A
N/A
EPS Growth
650.00
N/A
EPS
N/A
N/A
Revenue
$348,975,000.00
N/A
Revenue This Year
$12.84
$124.49
Revenue Next Year
$9.11
$353.99
P/E Ratio
N/A
N/A
Revenue Growth
16.34
N/A
52 Week Low
$1.65
$0.20
52 Week High
$2.87
$5.14

Technical Indicators

Market Signals
Indicator
OPAL
VTGN
Relative Strength Index (RSI) 45.86 39.89
Support Level $2.04 $0.21
Resistance Level $2.44 $0.32
Average True Range (ATR) 0.20 0.02
MACD -0.03 0.01
Stochastic Oscillator 13.38 16.67

Price Performance

Historical Comparison
OPAL
VTGN

About OPAL OPAL Fuels Inc.

OPAL Fuels Inc is a fully integrated leader in the capture and conversion of biogas into low-carbon-intensity renewable natural gas and Renewable Power. The company is also engaged in the marketing and distribution of RNG to heavy-duty trucking and other hard-to-decarbonize industrial sectors. The company designs, develops, constructs, operates, and services Fueling Stations for trucking fleets across the country that use natural gas to displace diesel as their transportation fuel. The company derives revenue from the sale of Renewable Power, design, development, construction, and service of Fueling Stations, and sales of RNG produced by OPAL and third parties as pipeline-quality natural gas. The Company has three operating segments: RNG Fuel, Fuel Station Services, and Renewable Power.

About VTGN VistaGen Therapeutics Inc.

Vistagen Therapeutics Inc is a late clinical-stage therapeutics company focused on developing and commercializing medicines for patients with social anxiety disorder, depression, menopausal hot flashes, psychomotor impairment due to mental fatigue, and cancer cachexia. The company is engaged in developing intranasal product candidates called pherines, which leverage the understanding of nose-to-brain neurocircuitry. Vistagen's pherine pipeline consists of various product candidates like: Fasedienol, Itruvone, PH15, Refisolone, and PH284, which are being developed to provide treatment for a variety of disorders. Additionally, it is seeking potential partners for the further clinical development and commercialization of an oral drug candidate, AV-101, to treat certain neurological disorders.

Share on Social Networks: